Clinical trial
Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)
NCT06672510 is registered in ClinicalTrials.gov with Akura Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)
- Lead sponsor
- Akura Medical
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- January 27, 2025
- Completion date
- September 30, 2028
- Enrollment
- 118 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary embolism acute